Suitability of an Infant Formula With L-5-Methyltetrahydrofolate for the Particular Nutritional Use in Infants (MEFOLIN)
Sponsor: Bevital AS
Listed as NCT02437721, this NA trial focuses on Growth and Development and remains completed. Sponsored by Bevital AS, it has been updated 11 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Mar 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Mar 2026 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2019 — Jan 2021 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Sep 2018 — Mar 2019 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2017 — Feb 2018 [monthly]
Recruiting NA
-
May 2017 — Jul 2017 [monthly]
Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Recruiting NA
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bevital AS
- Charite University, Berlin, Germany
- HiPP GmbH & Co. Vertrieb KG
- Institute for Laboratory Diagnostics Konzilijum
- Ludwig-Maximilians - University of Munich
- Sermon CRO
- University Clinic Dr Dragisa Misovic-Dedinje
- dsm-firmenich Switzerland AG
For direct contact, visit the study record on ClinicalTrials.gov .